...

首页> 外文期刊>Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis >Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations

【24h】

Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations

机译：我们是否应该为亚洲心房颤动患者提供2.0至3.0的标准国际标准化比率范围？对基于证据的管理的上诉，而不是基于卓越的建议

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis》 |2020年第3期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献

1. Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations [J] . Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2020,第3期

机译：我们是否应该为亚洲心房颤动患者提供2.0至3.0的标准国际标准化比率范围？对基于证据的管理的上诉，而不是基于卓越的建议
2. Anticoagulation intensity for elderly atrial fibrillation patients: Should we use a conventional INR target (2.0 to 3.0) or a lower range? [J] . Deirdre A. Lane, Gregory Y. H. Lip Thrombosis and Haemostasis: Journal of the International Society on Thrombosis and Haemostasis . 2010,第2期

机译：老年房颤患者的抗凝强度：我们应该使用常规的INR目标值（2.0到3.0）还是更低的范围？
3. COST OF VISITS ASSOCIATED WITH MANAGEMENT OF INTERNATIONAL NORMALIZED RATIO (INR) RESULTS IN ATRIAL FIBRILLATION (AF) PATIENTS TREATED WITH VITAMIN K ANTAGONIST (VKA) [J] . Ansolabehere X., Augier G. Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2017,第5期

机译：与国际标准化比率管理相关的访问成本（INR）导致用维生素K拮抗剂治疗的心房颤动（AF）患者（VKA）
4. Risk factors for ischemic stroke in patients with non-valvular atrial fibrillation and therapeutic international normalized ratio range [O] . Paweł Wańkowicz, Przemysław Nowacki, Monika Gołąb-Janowska 2019

机译：非瓣膜性心房颤动患者缺血性卒中的危险因素及国际标准化治疗率范围
5. Should We Adopt a Standard International Normalized Ratio Range of 2.0 to 3.0 for Asian Patients with Atrial Fibrillation? An Appeal for Evidence-Based Management, Not Eminence-Based Recommendations [O] . Tze-Fan Chao, Yutao Guo 2020

机译：我们是否应该为亚洲心房颤动患者提供2.0至3.0的标准国际标准化比率范围？对基于证据的管理的上诉，而不是基于卓越的建议

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号